Last Updated on Nov 26, 2016

Latest Publications and Research on Rhabdomyosarcoma

Pediatr Blood Cancer  2020 Jan 28  

An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.

Bisogno G, Hawkins DS

Clinical trials have tested different chemotherapy regimens to improve outcome for patients with rhabdomyosarcoma (RMS), but therapy duration has neve... Read More

Source: PubMed

Cancer Metastasis Rev.  2020 Jan 27  

Signaling pathways in Rhabdomyosarcoma invasion and metastasis.

Ramadan F, Fahs A, Ghayad SE, Saab R

Rhabdomyosarcoma (RMS) is an aggressive childhood mesenchymal tumor with two major molecular and histopathologic subtypes: fusion-positive (FP)RMS, ch... Read More

Source: PubMed

Pathol. Int.  2020 Jan 30  

A rare case of congenital spindle cell rhabdomyosarcoma with TEAD1-NCOA2 fusion: A subset of spindle cell rhabdomyosarcoma with indolent behavior.

Tan GZL, Saminathan SN, Chang KTE, Odoño EG, Kuick CH, Chen H, Lee VKM

... Read More

Source: PubMed

Acta Chir. Belg.  2020 Jan 29  

Successful outcome following resection of metachronous pancreatic metastasis from a rhabdomyosarcoma.

Monge M, Chiavelli H, Pinson J, Papet E, Schwarz L, Tuech JJ

Background: Pancreatic metastases (PM) are rare, comprising 3% of pancreatic tumours removed in sizable series of operations. This report presents the... Read More

Source: PubMed

Am. J. Surg. Pathol.  2020 Jan 27  

Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.

McCluggage WG, Apellaniz-Ruiz M, Chong AL, Hanley KZ, Velázquez Vega JE, McVeigh TP, Foulkes WD

DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosar... Read More

Source: PubMed

Most Popular on Medindia